Australia: Japan Enacts Regenerative Medicine Law and Revisions to Pharmaceutical Affairs Law

Food, Drugs, Medical Devices and Cosmetics Alert
Last Updated: 24 December 2013
Article by Naoki Watanabe and Ayuko Nemoto

On 20 November 2013, the Japanese Diet passed the Act regarding Ensuring of Safety of Regenerative Medicine (the "Regenerative Medicine Law") and the revisions to the Pharmaceutical Affairs Law (new PAL) as it applies to drugs, medical devices and regenerative medicine. Both laws will come into effect some time within one year from the date of promulgation. Also, on 5 December 2013, a bill to partially revise the Pharmaceutical Affairs Law and the Pharmacists Act, which regulate online sales of drugs (Online Sales Bill) was approved by the Diet. It will come into effect some time within six months from the date of promulgation.

This Legal Insight analyzes the main points of these three new rules.

Regenerative Medicine Law


For the first time, the Regenerative Medicine Law sets out the definitions of regenerative medicine and criteria for:

  1. organizations that provide regenerative medicine
  2. manufacturers of specific cell products, and
  3. cell culture processing facilities.

With these new rules, Japan intends to expedite the use of regenerative medicine as to ensure the safety of such use.

New Rules Under the Regenerative Medicine Law

The Regenerative Medicine Law categorizes and regulates three types of 'Regenerative Medical Techniques'.

First, before a medical institution provides regenerative medicine to patients for the purpose of treatment, it is required to:

  1. submit a plan for the provision of such regenerative medicine, and
  2. to meet the criteria regarding the provision of regenerative medicine set out in the Ordinance of the Ministry of Health, Labour and Welfare (MHLW).

The types of regenerative medicine covered by the Regenerative Medicine Law are as follows:

Type Definitions Examples

Type I

Regenerative Medical Techniques

Regenerative Medical Techniques the effect of which is not clear or which may significantly affect the life or health of human beings even with reasonable care and which is specified in the Ordinance of the MHLW. Regenerative medicine with induced pluripotent stem cells (iPS cells) or embryonic stem cells (ES cells) products.
Type II Regenerative Medical Techniques Regenerative Medical Techniques which may affect the life or health of human beings even with reasonable care and which is specified in the Ordinance of MHLW. Regenerative medicine with own-fat stem cells.

Type III

Regenerative Medical Techniques

Regenerative Medical Techniques other than Type I and II Regenerative Medicinal Techniques. Traditional cancer therapy with activated lymphocyte.

Second, the Regenerative Medicine Law enables medical institutes to outsource processing cell cultures to companies that are not medical institutes. Pursuant to the law, the companies processing cell cultures are subject to the regulation described below.

Types of manufacturers Cell culture processing manufacturer Foreign cell culture processing manufacturer Cell culture processing manufacturer with specific cell culture processing facilities (eg medical institutes)
Required process Permission Authorization Filing
  • Buildings and equipment used in the cell culture processing facilities must meet the criteria set out in the Ordinance of MHLW.
  • Cell culture processing facilities must have a staff member who has certain biological knowledge related to the specific cell products.
  • Manufacturers must comply with the criteria set out in the Ordinance of MHLW related to manufacturing, quality management, testing and inspection, storage, transportation, preparation and maintenance of records and periodical reports.



On 20 November 2013, a new law titled "Act on Assurance of Quality, Effectiveness and Safety of Drugs and Medical Devices, etc." (the "Pharmaceuticals and Medical Devices Act") was approved. In addition to the important changes described in our Global Food, Drug and Medical Device Newsletter, issued in Fall 2013, the following changes will be applicable.

New Rules under the New PAL

  1. Package Insert

The new PAL requires companies marketing and selling drugs, medical devices and regenerative medical products ("products") to provide cautions related to the use or handling of the products based on knowledge obtained by latest articles or other information. The part of language in the package insert is required to be filed to MHLW. An online announcement is also required.

Who Companies marketing and selling drugs, medical devices and regenerative medical products.

When preparing a package insert for the products.

Before marketing and selling the products.

Before revising the package insert.


Must provide cautions related to the use or handling of the products based on knowledge obtained by latest articles or other information.

A part of the language in the package insert is required to be filed to MHLW.

Online announcement is also required.

  1. License Requirements for Charge-Free Lease

Companies that lease "specially controlled medical devices" (higher risk medical devices) or certain "maintained and controlled medical devices" (which require professional knowledge and techniques for maintenance, inspection and repairs) for free in the course of trade must be licensed for such leasing. Currently, only a fee charging lease is subject to license requirement but this amendment expands the license requirement to the charge-free lease of medical devices.

Online Sales Bill


On 5 December 2013, the Online Sales Bill, which would allow online sales of over-the-counter (OTC) drugs directly to consumers, was approved by the Diet.

New Regulations

The following new rules for online sales are set out in the Online Sales Bill:

Type of Drugs Regulations
Non prescription drugs

Online sales are permitted.

Companies need to comply with new rules including providing necessary information to customers.

Drugs required to be guided Switched Drugs (Drugs which have been categorized as non prescription drugs from prescription drugs) Online sales are prohibited for a specific period (maximum three years). Online sales will be allowed after safety of the drugs is evaluated through post marketing surveillance.
Poisons Online sales are prohibited.
Prescription drugs Online sales are prohibited.

On 12 November 2013, a company conducting online drug sales took legal action against the Japanese Government, claiming that it is unconstitutional to prohibit online sales of Prescription Drug by ordinances. We will continue to monitor new developments and any potential revisions to regulations on online sales of these drugs.

Impact on Companies

The Regenerative Medicine Law, New PAL and Online Sales Bill will impact medical institutes, pharmaceutical companies, medical device companies and other companies in the medical field and we recommend that those entities review their internal rules for compliance and educate their employees on new regulations as they come into effect.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

K&L Gates has been awarded a 2012 EOWA Employer of Choice for Women citation acknowledging our commitment to workplace diversity.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Mondaq Advice Centre (MACs)
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.